Literature DB >> 7410809

Abnormal development of Hymenolepis nana larvae in immunosuppressed mice.

S B Lucas, O Hassounah, R Muller, M J Doenhoff.   

Abstract

Observations on the course of Hymenolepis nana infection in immunosuppressed mice are presented. Treatment of the host with hydrocortisone acetate caused superinfection of the bowel with worms and the development of normal cysticercoids in the mesenteric lymph node and liver. Natural infection of mice deprived of their T-cells by pre-adult thymectomy and administration of antithymocyte serum resulted in superinfection and widespread metastasis of aberrant cysticercoids that were greatly enlarged and without scolices, causing death after about five months. The significance of these findings and their possible relevance to human infection with H. nana are discussed.

Entities:  

Mesh:

Year:  1980        PMID: 7410809     DOI: 10.1017/s0022149x00006386

Source DB:  PubMed          Journal:  J Helminthol        ISSN: 0022-149X            Impact factor:   2.170


  4 in total

1.  Histopathological and biochemical studies on immunocompetent and immunocompromised Hymenolepis nana infected mice treated with Commiphora molmol (Mirazid).

Authors:  Ahmed Mohamed Sayed Bayoumy; Hanan Taher Hamza; Mashael Alhumaidi Alotabi
Journal:  J Parasit Dis       Date:  2020-08-27

2.  Rodent model for long-term maintenance and development of the viable cysticerci of Taenia saginata asiatica.

Authors:  I C Wang; W C Chung; S C Lu; P C Fan
Journal:  Korean J Parasitol       Date:  2000-12       Impact factor: 1.341

3.  Thymus dependency of induced immune responses against Hymenolepis nana (cestode) using congenitally athymic nude mice.

Authors:  A Ito
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

Review 4.  The effects of selective immunosuppression on resistance to Mesocestoides corti in strains of mice showing high and low initial susceptibility.

Authors:  T R White; R C Thompson; W J Penhale
Journal:  Z Parasitenkd       Date:  1983
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.